Abstract
High‐Throughput CRISPR/Cas9 Mediated Gene Editing of Primary Human T Cells in a Microfluidic Device for Cellular Therapy Manufacturing (Adv. Mater. Technol. 17/2023)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have